IQVIA Holdings Inc (IQV) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

IQVIA Holdings Inc (IQVIA), formerly Quintiles IMS Holdings, Inc, is a provider of information, novel technological solutions and contract research services, by harnessing data and science, to healthcare companies. The company offers a wide range of solutions in clinical development, commercialization and technologies, and helps stimulate significant healthcare outcomes. Its IQVIA CORE is a customized solution that provides actionable insights through big data, transformative technology and analytics with wide industry knowledge in diseases, regions, human behaviors and scientific advances. IQVIA serves biotech, medical device and pharmaceutical companies; medical researchers, government agencies, patient associations, payers and investigators, among others. The company has operations in Asia, Europe, the Americas, the Middle East and Africa. IQVIA is headquartered in Durham, North Carolina, the US.

IQVIA Holdings Inc (IQV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
IQVIA Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
IQVIA Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Quintiles IMS Holdings Acquires Clinical Trials Division from TKL Research 13
Partnerships 14
Quintiles Forms Joint Venture with Quest Diagnostics 14
Basilea Pharma Enters into Agreement with Quintiles to Commercialize Zevtera 15
Merck Serono Enters Into Clinical Development Agreement With Quintiles Transnational 16
Almirall Enters Into Commercialization Agreement With Quintiles 17
Quintiles Transnational Enters Into Co-Development Agreement With Allscripts Healthcare Solutions 18
HemoShear Enters Into Co-Development Agreement With Expression Analysis 19
Quintiles Transnational Enters Into Agreement With Dayarn Pharma 20
Licensing Agreements 21
Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 21
Equity Offering 22
IQVIA Holdings Prices Secondary Offering of Shares for USD828 Million 22
Quintiles IMS Holdings Raises USD857.25 Million in Secondary Public Offering of Shares 24
Quintiles IMS Holdings Raises Funds through Public Offering of Shares 26
Quintiles IMS Holdings Plans to Raise Funds through Public Offering of Shares 28
Quintiles Transnational Completes IPO For US$525 Million 29
Debt Offering 31
Quintiles IMS Raises USD504.8 Million in Public Offering of 2.875% Notes Due 2025 31
Quintiles Announces Private Placement of Notes Due 2023 for USD800 Million 32
Acquisition 33
Quintiles IMS to Acquire DrugDev 33
Quintiles Transnational Completes Acquisition of Encore Health Resources, Healthcare IT Company 34
Quintiles Transnational Completes Acquisition Of Novella Clinical Clinical Research Organization 35
Invesco Acquires Minority Stake In DrugDev For US$50 Million 36
Quintiles Acquires Expression Analysis 37
IQVIA Holdings Inc - Key Competitors 38
IQVIA Holdings Inc - Key Employees 39
IQVIA Holdings Inc - Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 47
Recent Developments 48
Financial Announcements 48
May 18, 2018: IQVIA reaffirms Q2 and full-year 2018 guidance 48
Feb 14, 2018: IQVIA Reports Fourth-Quarter and Full-Year 2017 Results, Issues First-Quarter and Full-Year 2018 Guidance 49
Oct 26, 2017: QuintilesIMS Reports Third-Quarter 2017 Results 51
Aug 03, 2017: QuintilesIMS reports second-quarter 2017 results 53
May 03, 2017: QuintilesIMS Reports First-Quarter 2017 Results and Raises Full-Year 2017 Adjusted Diluted EPS Guidance 55
Feb 14, 2017: QuintilesIMS Reports Fourth-Quarter and Full-Year 2016 Results, Issues First-Quarter and Full-Year 2017 Guidance 57
Corporate Communications 59
Jul 26, 2017: Colleen Goggins joins QuintilesIMS board of directors 59
Product News 60
Jun 21, 2018: IQVIA Launches a Transformative Suite of Virtual Research Solutions 60
Other Significant Developments 61
Nov 06, 2017: QuintilesIMS is now IQVIA 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List Of Tables

List of Tables
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
IQVIA Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
IQVIA Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 9
IQVIA Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Quintiles IMS Holdings Acquires Clinical Trials Division from TKL Research 13
Quintiles Forms Joint Venture with Quest Diagnostics 14
Basilea Pharma Enters into Agreement with Quintiles to Commercialize Zevtera 15
Merck Serono Enters Into Clinical Development Agreement With Quintiles Transnational 16
Almirall Enters Into Commercialization Agreement With Quintiles 17
Quintiles Transnational Enters Into Co-Development Agreement With Allscripts Healthcare Solutions 18
HemoShear Enters Into Co-Development Agreement With Expression Analysis 19
Quintiles Transnational Enters Into Agreement With Dayarn Pharma 20
Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 21
IQVIA Holdings Prices Secondary Offering of Shares for USD828 Million 22
Quintiles IMS Holdings Raises USD857.25 Million in Secondary Public Offering of Shares 24
Quintiles IMS Holdings Raises Funds through Public Offering of Shares 26
Quintiles IMS Holdings Plans to Raise Funds through Public Offering of Shares 28
Quintiles Transnational Completes IPO For US$525 Million 29
Quintiles IMS Raises USD504.8 Million in Public Offering of 2.875% Notes Due 2025 31
Quintiles Announces Private Placement of Notes Due 2023 for USD800 Million 32
Quintiles IMS to Acquire DrugDev 33
Quintiles Transnational Completes Acquisition of Encore Health Resources, Healthcare IT Company 34
Quintiles Transnational Completes Acquisition Of Novella Clinical Clinical Research Organization 35
Invesco Acquires Minority Stake In DrugDev For US$50 Million 36
Quintiles Acquires Expression Analysis 37
IQVIA Holdings Inc, Key Competitors 38
IQVIA Holdings Inc, Key Employees 39
IQVIA Holdings Inc, Other Locations 40
IQVIA Holdings Inc, Subsidiaries 40
IQVIA Holdings Inc, Joint Venture 47

List Of Figures

List of Figures
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
IQVIA Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10

IQVIA Holdings Inc (IQV) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

IQVIA Holdings Inc (IQVIA), formerly Quintiles IMS Holdings, Inc, is a provider of information, novel technological solutions and contract research services, by harnessing data and science, to healthcare companies. The

USD 250 View Report

IQVIA Holdings Inc (IQV) - Medical Equipment - Deals and Alliances Profile

IQVIA Holdings Inc (IQVIA), formerly Quintiles IMS Holdings, Inc, is a provider of information, novel technological solutions and contract research services, by harnessing data and science, to healthcare companies. The

USD 250 View Report

Matinas BioPharma Holdings Inc (MTNB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Matinas BioPharma Holdings Inc (Matinas BioPharma) is a clinical-stage biopharmaceutical company that discovers and develops anti-infectives for orphan indications. The company develops lipid nano-crystal (LNC) technology, a drug delivery platform

USD 250 View Report

Bartlett Holdings Inc - Power - Deals and Alliances Profile

Bartlett Holdings Inc, doing business as BHI Energy, a subsidiary of AE Industrial Partners LLC, is a specialty service and staffing solutions provider. The company offers complete maintenance, radiological and

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available